论文部分内容阅读
目的:观察和评价多索茶碱疗治慢性阻塞性肺疾病(COPD)的临床疗效。方法:将74例COPD患者分为多索茶碱组(A组)和氨茶碱组(B组),观察两组患者治疗前后的临床效果及不良反应发生率。结果:A组临床总有效率高于B组,且不良反应发生率低,治疗前后肺功能和血气分析主要指标差异有统计学意义(P<0.05)。结论:多索茶碱是一种安全有效的治COPD的药物。
Objective: To observe and evaluate the clinical efficacy of doxofylline in the treatment of chronic obstructive pulmonary disease (COPD). Methods: A total of 74 patients with COPD were divided into the doxofylline group (A group) and the aminophylline group (B group). The clinical effect and incidence of adverse reactions in both groups before and after treatment were observed. Results: The total clinical effective rate in group A was higher than that in group B, and the incidence of adverse reactions was low. There were significant differences in the main indexes of pulmonary function and blood gas analysis before and after treatment (P <0.05). Conclusion: Doxofylline is a safe and effective drug for COPD.